Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
Authors
Keywords
-
Journal
Oncogenesis
Volume 6, Issue 10, Pages e384
Publisher
Springer Nature
Online
2017-10-02
DOI
10.1038/oncsis.2017.84
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Down-regulation of histone deacetylase 4, −5 and −6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin
- (2017) Yukiko Oya et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- Heterogeneity of tumor endothelial cells and drug delivery
- (2016) Kyoko Hida et al. ADVANCED DRUG DELIVERY REVIEWS
- Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment
- (2016) Byung-Hak Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway
- (2016) Yunes Panahi et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Genome-wide analysis of the effect of esophageal squamous cell carcinoma on human umbilical vein endothelial cells
- (2016) GUOGUO JIN et al. ONCOLOGY REPORTS
- Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
- (2016) Yoo Seob Shin et al. PHYTOMEDICINE
- The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2016) Kun Ji et al. PLoS One
- Synthetic stigmasterol derivatives inhibit capillary tube formation, herpetic corneal neovascularization and tumor induced angiogenesis
- (2016) Flavia M. Michelini et al. STEROIDS
- Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms
- (2016) Teng-Fei Yin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma
- (2016) Xiang Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention
- (2015) Alexandra M. Fajardo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinoma
- (2015) YANAN JIANG et al. ONCOLOGY REPORTS
- Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway
- (2015) LICHUAN WU et al. ONCOLOGY REPORTS
- Cancer prevention and therapy through the modulation of the tumor microenvironment
- (2015) Stephanie C. Casey et al. SEMINARS IN CANCER BIOLOGY
- Broad targeting of angiogenesis for cancer prevention and therapy
- (2015) Zongwei Wang et al. SEMINARS IN CANCER BIOLOGY
- Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
- (2015) Jichang Wang et al. Oncotarget
- 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells
- (2015) Yi Zhang et al. Oncotarget
- Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway
- (2015) Zhongping Fu et al. Oncotarget
- Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells
- (2014) Tsuguteru Otsubo et al. CANCER SCIENCE
- Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization
- (2014) Elena Magrini et al. JOURNAL OF CLINICAL INVESTIGATION
- ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients
- (2013) J Lu et al. BRITISH JOURNAL OF CANCER
- JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma
- (2013) Jing Lu et al. CARCINOGENESIS
- Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation
- (2012) David A. Braun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer
- (2012) Su-Ni Tang et al. PLoS One
- Tumor exploits alternative strategies to achieve vascularization
- (2011) Benedetta Bussolati et al. FASEB JOURNAL
- CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
- (2011) Kwan Ho Tang et al. HEPATOLOGY
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- New Role of (-)-Epicatechin in Enhancing the Induction of Growth Inhibition and Apoptosis in Human Lung Cancer Cells by Curcumin
- (2010) A. Saha et al. Cancer Prevention Research
- New cancer treatment strategy using combination of green tea catechins and anticancer drugs
- (2010) Masami Suganuma et al. CANCER SCIENCE
- MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma
- (2010) Jing Lu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Synergy research: Approaching a new generation of phytopharmaceuticals
- (2010) Hildebert Wagner FITOTERAPIA
- Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies
- (2008) Kyoko Hida et al. CANCER SCIENCE
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search